Sabine Bleiziffer
Latest contributions
Improving Heart Function (iHF): Driving trans-disciplinary innovation in heart failure care
25 Aug 2025
Improving Heart Function (iHF) is a scientific and educational initiative which aims to address the complexity of heart failure care with a trans-disciplinary vision and high-level clinical resources.
Overcoming anatomical challenges in the lifetime management of young TAVI patients
27 Mar 2025
Watch this replay with D. Tchetche, S. Bleiziffer, D. Dvir and D. Talreja and learn about the criteria for valve selection before TAVI in young patients, and so much more!
Transcatheter mitral intervention for failed surgical valves and rings - The toolkit
26 Nov 2024 – From PCR London Valves 2024
Looking to enhance your approach to failed surgical mitral valves and rings? This video is a must-watch!
You’ll explore patient selection, master the steps of mitral valve-in-valve and valve-in-ring procedures, and learn strategies like valve cracking and LAMPOON to overcome key challenges.
TAV-in-SAV for surgical bioprosthetic valve failure
26 Nov 2024 – From PCR London Valves 2024
Dive into the intricacies of TAV-in-SAV procedures for failed surgical bioprosthetic valves. Gain a comprehensive understanding of the key information needed to evaluate a failed surgical bioprosthesis before considering a valve-in-valve intervention. Learn strategies to avoid high gradients and patient-prosthesis mismatch, and explore the clinical relevance...
Patient-driven strategies to improve women's experience of heart valve disease: better partnerships for better outcomes
25 Nov 2024 – From PCR London Valves 2024
Curious about how to improve care for women with heart valve disease?
Join this session to explore patient-centred strategies, gain insights from the latest SMART data and dive into the RHEIA trial. You’ll learn how to integrate shared decision-making and strengthen Heart Team partnerships to deliver better outcomes...
Transcatheter mitral valve replacement - Are we there yet?
25 Nov 2024 – From PCR London Valves 2024
Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!
Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...
TAVI for pure aortic regurgitation - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on aortic regurgitation:
- An 86-year-old male with a history of stroke and prostate cancer presenting acute heart failure due to severe pure aortic regurgitation and LV dysfunction (EF 39%). A 27 mm JenaValve Trilogy prosthesis was implanted without...
Focus on TAVI in female patients
25 Oct 2024
Didier Tchetche, Sabine Bleiziffer, Philippe Généreux, and Julia Mascherbauer explore the latest evidence about women and aortic stenosis.
To repair or to replace the mitral valve: that is the question
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive understanding of both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) techniques, including their respective advantages, suitability criteria, and clinical outcomes. The session features insights from a surgeon's perspective on the considerations and techniques involved in mitral valve repair...
Innovation and strategies in TAVI: design, data and directions for clinical practice
15 May 2024 – From EuroPCR 2024
Watch this session to explore considerations for TAVI implantation in small annuli, gain insights into future lifetime management, learn about the benefits of FX technology and clinical evidence beyond small annuli, and witness a live case procedure showcasing the innovation of FX plus. This session is...
Major Late-Breaking Trials from EuroPCR 2024
15 May 2024 – From EuroPCR 2024
This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
How will the SMART trial results impact our practice and decision making in TAVI?
16 May 2024 – From EuroPCR 2024
Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
TAVI in complex scenarios - Prevention and management of acute coronary obstruction
20 Nov 2023 – From PCR London Valves 2023
Although acute coronary obstruction remains rare, it is a dramatic complication during TAVI: find out how to predict this preventable obstruction in different clinical scenarios by learning the key steps of the chimney stenting and BASILICA techniques, and get a glimpse into the future to learn...
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
Complex transcatheter mitral and tricuspid interventions - Recorded cases
20 Nov 2023 – From PCR London Valves 2023
This session features two compelling cases of percutaneous annuloplasty for advanced heart failure and massive tricuspid regurgitation:
- Left ventricular restoration in heart failure with reduced ejection fraction
A 56-year-old male, with type 2 diabetes, hypertension and chronic kidney disease, presented a symptomatic severe LV dysfunction (26%) and severely...
Challenges in TAVIs, are there guideline recommendations?
20 Nov 2023 – From PCR London Valves 2023
The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...
Second time TAVI (TAV-in-TAV) - Not as simple as it looks
19 Nov 2023 – From PCR London Valves 2023
Although it is still rare, TAV-in-TAV is likely to become more frequent, as TAVI is increasingly implanted in younger patients. Harmonizing data in this area will therefore help to improve outcomes, the quality of which depends on site experience, bearing in mind that for the time...
Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?
19 Nov 2023 – From PCR London Valves 2023
Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...
Controversies in atrioventricular valves - The Heart Team ring, Vol II
19 Nov 2023 – From PCR London Valves 2023
This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.
Transcatheter mitral repair and replacement for primary mitral regurgitation - LIVE case
19 Nov 2023 – From PCR London Valves 2023
This session aims to highlight the remarkable advancements achieved in transcatheter mitral valve intervention over the past two decades, since its inception. Follow two TEER cases which illustrate this rapidly growing field:
- Transcatheter edge-edge mitral valve repair
A 77-year-old male with a history of SAVR (bioprothesis) + LIM-LAD/Diag, normal...
Which valve for which patient? - Part 2: complex anatomy
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.
TAVI for bicuspid anatomy: beyond type I LR
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand the challenges of bicuspid aortic stenosis patients, type 0 in particular, to review contemporary sizing methods in bicuspid aortic stenosis, and to tailor the implant technique to individual patient.
How achieving optimal index procedural outcomes can positively influence future TAVI treatment options
23 Feb 2023
Watch the replay of this webinar to understand the impact of procedural outcomes on future TAVI treatment options, and much more!
How should we treat low risk patients with aortic stenosis?
10 Feb 2021
Watch the replay of this PCR Webinar on TAVI with N. Dumonteil, T. Modine and S. Bleiziffer
How should Heart Teams adapt to recently-updated valvular heart disease guidelines?
31 Jan 2022
Discover the replay of this PCR Webinar on TAVI with N. Piazza, S. Bleiziffer and J. Bax.
Management of a patient with severe CAD and aortic valve stenosis
20 May 2022 – From EuroPCR 2022
Watch the LIVE case of an 87-year-old male patient with a history of hypertension and dyslipidemia but no other significant cardiovascular risk factors and remarkably good health for an elderly man, but with angina for some months and dyspnea, and discuss the management of TAVI candidates with...
EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...
The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.
